Tag: drug trial
Novo Nordisk drug fails to cut heart attacks, unsettling a leading heart-disease theory
Ziltivekimab lowered inflammation as designed, but did not prevent cardiovascular events in a large phase 3 trial.
Follow our social media channels to stay updated on the latest health news.
© 2026 Welltica. All rights reserved.
